Tiny drops, big questions: new study eyes steroid safety in preemies
NCT ID NCT05387941
First seen May 02, 2026 · Last updated May 13, 2026 · Updated 3 times
Summary
This study looked at how steroid eye drops are absorbed and processed in premature babies who have an eye disease called retinopathy of prematurity (ROP). Eleven infants received the drops, and researchers took small blood and saliva samples to measure the drug levels. The goal was to learn about safety and how the body handles the medication, not to prove it works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETINOPATHY OF PREMATURITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sahlgrenska University Hospital
Gothenburg, Västra Götaland County, 41685, Sweden
-
Skåne University Hospital
Lund, Skåne County, 22185, Sweden
Conditions
Explore the condition pages connected to this study.